Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Much Is the Global Humira Drug Market Valued at Present and by 2029?

In recent years, the Humira drug market has experienced significant growth. It’s estimated that this market, worth $9.74 billion in 2024, will increase to a valuation of $10.33 billion in 2025, reflecting a compound annual growth rate (CAGR) of 6.0%. The growth during the historic period is due to factors such as the advent of biologics, advances in biotechnology, increasing patient demand for efficient treatments, and changes in physician adoption and prescribing habits.

Over the coming years, there is a forecast of robust growth in the market size for Humira drug. The market size is anticipated to reach $13.93 billion by 2029 with a compound annual growth rate (CAGR) of 7.8%. The drivers of this growth during the forecast period include entry of biosimilars into the market, modifications in healthcare policies, emphasis on cost-effectiveness, investments in research and development, precision medicine, and customized treatments. Major trends in the anticipated period include the generation of real-world evidence, wider usage in pediatric groups, a shift towards self-administered drugs, value-based pricing strategies, and the development of targeted therapies.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=11934&type=smp

#What Drivers Are Influencing Growth In The Humira Drug Market?

The escalation in the occurrence rate of autoimmune disease is anticipated to boost the expansion of the humira drug market in the future. An autoimmune disease involves the body’s immune system turning against and demolishing healthy cells and tissues in the body. The humira drug is employed for treating pain and inflammation instigated by various autoimmune diseases, hence, escalating incidence rate of autoimmune diseases elevate the demand for humira drug. For example, in March 2024, the National Health Council, a non-profit organization based in the US, reported that around 50 million Americans are affected by autoimmune diseases. However, due to the intricacies in diagnosing these diseases, this number is possibly underestimated. What is even more alarming, is that autoimmunity is nearing epidemic levels, with certain studies pointing to an annual growth of 3-12%. Consequently, the escalation in the occurrence rate of autoimmune disease will fuel the HUMIRA drug market.

What Are The Main Segments Identified In The Humira Drug Market Research?

The humira drug market covered in this report is segmented –

1) By Type: Humira Syringe, Humira Pen

2) By Application: Ankylosing Spondylitis, Rheumatoid Arthritis, Crohn’s Disease, Other Applications

3) By End-Users: Hospitals, Specialty Clinics, Other End-Users

Subsegments:

1) By Humira Syringe: Pre-Filled Syringe, Disposable Syringe

2) By Humira Pen: Auto-Injector Pen, Pre-Filled Injection Pen

What Are The Leading Trends And Opportunities In The Humira Drug Sector?

Innovations in product are a leading trend in the market for humira drugs. Big players in this market are evolving new biologics and biosimilars to retain their market stronghold. For instance, Sandoz, a pharmaceutical firm based in Switzerland unveiled Biosimilar Hyrimoz (adalimumab), a citrate-free high-concentration formulation (HCF) certified by the European Commission in April 2023. This adalimumab, a citrate-free HCF (100 mg/mL) formulation, results in a 50% decrease in injection volume and reduces the number of injections necessary for patients who choose dosing of 80 mg/mL or more. This is suitable for a range of conditions such as rheumatic diseases, Crohn’s disease and others, thereby improving the patient experience.

Which Companies Play A Key Role In The Development Of The Humira Drug Market?

Major companies operating in the humira drug market include Pfizer Inc., Merck & Co. Inc., AbbVie Inc., Novartis AG, Fresenius Kabi AG, Amgen Inc., Boehringer Ingelheim International GmbH, Viatris Inc., Sandoz International GmbH, Hikma Pharmaceuticals PLC, Celltrion Healthcare Co. Ltd., Cadila Pharmaceuticals Ltd., Torrent Pharmaceuticals Ltd., Mochida Pharmaceutical Co. Ltd., Innovent Biologics Inc., Biocad Biopharmaceutical Company, Shanghai Henlius Biotech Inc., Glenmark Pharmaceuticals Ltd., Samsung Bioepis Co Ltd., Hetero Healthcare Ltd., Coherus BioSciences Inc., CinnaGen Co., Alvotech Holdings S.A, Reliance Life Sciences Private Limited, Momenta Pharmaceuticals Inc., Bio-Thera Solutions Ltd., Fujifilm Kyowa Kirin Biologics Co. Ltd., BioXpress Therapeutics SA, Alteogen Inc., Prestige BioPharma Pte. Ltd.

Get The Full Report Here:

https://www.thebusinessresearchcompany.com/report/humira-drug-global-market-report

What Are The Key Regional Developments Shaping The Humira Drug Market?

North America was the largest region in the humira drug market in 2024. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the humira drug market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=11934&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model